Evidence map›Paper›PMID 40095113›Full record

ReviewCurrent neurology and neuroscience reports2025

Insights on the Shared Genetic Landscape of Neurodevelopmental and Movement Disorders.

Elisabetta Indelicato, Michael Zech, Anna Eberl, Sylvia Boesch

Abstract readReview
In one paragraph

Review in Current neurology and neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elisabetta IndelicatoCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Anichstrasse 35, Innsbruck, 6020, Austria. elisabetta.indelicato@i-med.ac.at.ORCID http://orcid.org/0000-0003-0217-8630
Michael ZechInstitute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-8112-9153
Anna EberlCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Anichstrasse 35, Innsbruck, 6020, Austria.
Sylvia BoeschCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Anichstrasse 35, Innsbruck, 6020, Austria.ORCID http://orcid.org/0000-0003-1657-7368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewLarge-scale studies using hypothesis-free exome sequencing have revealed the strong heritability of neurodevelopmental disorders (NDDs) and their molecular overlap with later-onset, progressive, movement disorders phenotypes. In this review, we focus on the shared genetic landscape of NDDs and movement disorders. RECENT

findingsCumulative research has shown that up to 30% of cases labelled as "cerebral palsy" have a monogenic etiology. Causal pathogenic variants are particularly enriched in genes previously associated with adult-onset progressive movement disorders, such as spastic paraplegias, dystonias, and cerebellar ataxias. Biological pathways that have emerged as common culprits are transcriptional regulation, neuritogenesis, and synaptic function. Defects in the same genes can cause neurological dysfunction both during early development and later in life. We highlight the implications of the increasing number of NDD gene etiologies for genetic testing in movement disorders. Finally, we discuss gaps and opportunities in the translation of this knowledge to the bedside.

Indexed as

Genetic Predisposition to DiseaseMovement DisordersNeurodevelopmental DisordersHumansCACNA1ACerebral palsyDystoniaExome sequencingMovement disordersNeurodevelopmental disorders

Identifiers

PMID40095113
PMCPMC11914236

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.